换一批Phase Ib study of drozitumab combined with first-line mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
第一作者：
Caio M,Rocha Lima
第一单位：
Division of Hematology/Oncology University of Miami, and Sylvester Comprehensive Cancer Center, University of Miami Hospital & Clinics, Miami, Florida 33136, USA.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌(Carcinoma);结直肠肿瘤(Colorectal Neoplasms);无病生存(Disease-Free Survival);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);免疫组织化学(Immunohistochemistry);醛氢叶酸(Leucovorin);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);有机铂化合物(Organoplatinum Compounds)
DOI
10.3109/07357907.2012.732163
PMID
23061802
发布时间
2020-12-19
- 浏览2
Cancer investigation
727-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
